Oxindole compounds
    7.
    发明授权
    Oxindole compounds 失效
    羟吲哚化合物

    公开(公告)号:US08124649B2

    公开(公告)日:2012-02-28

    申请号:US12495666

    申请日:2009-06-30

    摘要: The invention provides compounds that inhibit PIM kinases and Flt3 kinase, and compositions containing such compounds. These compounds and compositions are useful for treating proliferative disorders such as cancer, as well as other kinase-associated conditions including inflammation.

    摘要翻译: 本发明提供抑制PIM激酶和Flt3激酶的化合物,以及含有这些化合物的组合物。 这些化合物和组合物可用于治疗增殖性疾病如癌症,以及其它激酶相关病症,包括炎症。

    Therapeutic kinase modulators
    9.
    发明授权
    Therapeutic kinase modulators 有权
    治疗性激酶调节剂

    公开(公告)号:US07910600B2

    公开(公告)日:2011-03-22

    申请号:US12201892

    申请日:2008-08-29

    摘要: The invention relates in part to molecules having certain biological activities that include, but are not limited to, inhibiting cell proliferation, and modulating protein kinase activity. Molecules of the invention can modulate casein kinase (CK) activity. The invention also relates in part to methods for using such molecules.

    摘要翻译: 本发明部分地涉及具有某些生物活性的分子,包括但不限于抑制细胞增殖和调节蛋白激酶活性。 本发明的分子可以调节酪蛋白激酶(CK)活性。 本发明还部分涉及使用这种分子的方法。